81° F
May
22
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Regeneron Pharmaceuticals Incorporated

Highlights

A collection of news and information related to Regeneron Pharmaceuticals Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 12
» View baltimoresun.com items only
    May 21, 2013 |Story| Reuters

  1. U.S. RESEARCH ROUNDUP: Microsoft, ICE, Actavis, Boeing

    Reuters
    May 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Actavis, and Microsoft, on Tuesday. HIGHLIGHTS * Microsoft Corp : Janney, UBS raise price target on stock * Boeing : UBS...

    Tags: Deutsche Bank AG, Prices, Finance, TiVo Inc., LinkedIn Corp.

    2. May 21, 2013 |Story| Reuters

  2. Regeneron, Sanofi asthma drug seen as potential game changer

    Reuters
    (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said...

    Tags: Trials, Placebo, Respiratory Disease, Chemical Industry, Inflammation

    3. May 17, 2013 |Story| Reuters

  3. U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney

    Reuters
    May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...

    Tags: Celgene Corporation, Crown Castle International Corporation, Citigroup Incorporated, Liberty Global Incorporated, Deutsche Bank AG

    4. May 14, 2013 |Story| Reuters

  4. Sanofi recruits patients for arthritis trials

    Reuters
    PARIS (Reuters) - French drugmaker Sanofi SA said it and U.S. firm Regeneron Pharmaceuticals have started recruiting patients for two new trials of their arthritis treatment sarilumab. The drug is seen as one of several promising treatments in the...

    Tags: Trials, Arthritis

    5. May 6, 2013 |Story| Reuters

  5. U.S. RESEARCH ROUNDUP: Apple, Berkshire Hathaway, Walt Disney, AIG

    Reuters
    May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, Berkshire Hathaway and Walt Disney, on Monday. HIGHLIGHTS * Apple : Barclays ups target price to $525 from $465; rating...

    Tags: Berkshire Hathaway Inc., Deutsche Bank AG, Citigroup Incorporated, Pepco Holdings Incorporated, United Natural Foods Incorporated

    6. May 3, 2013 |Story| Reuters

  6. Regeneron raises 2013 Eylea sales view, profit beats Street

    Reuters
    May 3 (Reuters) - Regeneron Pharmaceuticals Inc's first-quarter results beat analysts' estimates for the seventh straight quarter as the sales of its eye drug Eylea continued to gather pace, and the company raised its 2013 sales estimate for the drug....

    Tags: Thomson Corporation, Earnings Forecasts, Companies and Corporations, Roche Holding AG, Macular Degeneration

    7. May 1, 2013 |Story| Reuters

  7. U.S. RESEARCH ROUNDUP: Berkshire, Fortinet, Aetna, NextEra Energy

    Reuters
    May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...

    Tags: Berkshire Hathaway Inc., Prices, Wisconsin Energy Corporation, Government, Seaspan Corporation

    8. May 1, 2013 |Story| Reuters

  8. BRIEF-Regeneron Pharma shares halted, last up 14.3 pct

    Reuters
    NEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares halted, last up 14.3 percent
    9. May 1, 2013 |Story| Reuters

  9. BRIEF-Regeneron Pharma shares resume trading, up 16 percent

    Reuters
    NEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval likely delayed * Shares up 13.2 percent as shares of Allergan slide after co...

    Tags: Allergan Inc.

    10. Apr 30, 2013 |Story| Reuters

  10. U.S. RESEARCH ROUNDUP: Time Warner, Walt Disney, Riverbed Technology

    Reuters
    April 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Walt Disney and Microsoft, on Tuesday. HIGHLIGHTS * Walt Disney : Evercore raises price target to $68 from $58; rating...

    Tags: Lear Corporation, Dresser-Rand Group Incorporated, Arch Capital Group Limited, Pandora Media, Inc., Deutsche Bank AG

    11. Apr 24, 2013 |Story| Reuters

  11. BRIEF-S&P 500 to add Regeneron, drop MetroPCS

    Reuters
    April 24 (Reuters) - * S&P says to add Regeneron Pharmaceuticals Inc to S&P 500 * S&P says Regeneron to replace MetroPCS Communications Inc which is expected to merge with t-Mobile USA inc * S&P says change to be made after close of trading on April 30

    Tags: Stock Market, S&P 500

    12. Apr 24, 2013 |Story| Reuters

  12. BRIEF-Regeneron Pharma shares up 2.8 pct after the bell

    Reuters
    NEW YORK, April 24 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares up 2.8 percent after the bell, to join S&P 500 next week

    Tags: S&P 500

Original site for Regeneron Pharmaceuticals Incorporated topic gallery.